Although these markers of amyloid and tau are indicative of the major features of the disease, they do not represent the full spectrum of pathological processes occurring in the brains of individuals with AD, such as neuroinflammation mediated by astro‐ and microglial activation. Here, MAPT is linked to Alzheimer disease.